Is rubididine available in China? Is it easy to buy

Introduction: Lurbinectedin, as an innovative RNA polymerase II inhibitor, has attracted much attention since its development. In China, rupitidine has passed the strict approval process and was successfully launched on the market, bringing new treatment hope to many patients with metastatic small cell lung cancer (SCLC). But for patients, how to buy and what to pay attention to when taking the medicine are equally important. This article will explain in detail the listing status, purchasing channels and medication precautions of rubidine in China in sections.

Rubitidine’s launch in China

Rubitidine has been successfully launched in China, providing patients with more treatment options. According to the latest news, the drug has been approved by the National Medical Products Administration in mainland China and has been included in the list of priority review varieties. In addition, rubidine has also received marketing approval in Hong Kong and Macau, China, and has benefited patients across the country through the "Hong Kong and Macau Drug and Device Linkage" policy in the Guangdong-Hong Kong-Macao Greater Bay Area. These initiatives undoubtedly bring good news to SCLC patients, allowing them to more conveniently obtain treatment with this innovative drug.

Purchasing channels of rubitidine

For patients, there are mainly the following channels to purchase rubitidine:

Hospital pharmacies: The pharmacies of most tertiary-level hospitals and some second-level hospitals will stock prescription drugs such as rubitidine. Patients need to go to the hospital pharmacy to purchase with the prescription issued by the doctor.

Online drug purchasing platforms: With the development of Internet medical care, more and more patients choose to purchase drugs through online drug purchasing platforms. However, since lupitidine is a prescription drug, patients must have a doctor’s prescription and upload it to the platform before purchasing it.

Drug Precautions

When using rupitidine, patients must strictly abide by the doctor's instructions and pay attention to the following matters:

Dosage and administration: The recommended dose of rupitidine is 3.2mg/m², intravenously infused for 60 minutes every 21 days. Patients need to calculate the specific dose based on their own body surface area and administer it under the guidance of a doctor.

Monitor adverse reactions: may cause a variety of adverse reactions, including fatigue, nausea, loss of appetite, vomiting, diarrhea, constipation, neutropenia, etc. Patients need to pay close attention to their own conditions during use and seek medical advice in time if they feel uncomfortable.

Avoid interactions with other drugs: When using rupitidine, patients should avoid concurrent use with other drugs that may interact. Please consult your doctor or pharmacist for details.

Use with caution in specific groups: Specific groups such as those with abnormal liver function, pregnant and lactating women, and patients with blood system diseases should use rubidine with caution. Full evaluation is required before use and use under the guidance of a doctor.

Storage Conditions: Rubitidine should be stored in a refrigerated environment at 2° to 8°C (36° to 46°F), away from direct sunlight and high temperatures.